Index Entries

1569 Results
TitleIS Publication Date
Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infectionOctober 25, 2021
Neurological Conditions Following COVID-19 Vaccinations: Chance or Association?February 04, 2022
Neurological side effects of SARS-CoV-2 vaccination are common and can be severeDecember 11, 2024
Neurological Side Effects of SARS-CoV-2 Vaccinations are Not Uncommon but Frequently IgnoredJune 27, 2022
Neuromuscular diseases associated with COVID-19 vaccines: a systematic review and pooled analysis of 258 patientsDecember 11, 2023
Neuropathic symptoms with SARS-CoV-2 vaccinationMay 17, 2022
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysisNovember 15, 2021
New COVID Select Memo Details Allegations of Wrongdoing and Illegal Activity by Dr. Fauci’s Senior Scientific AdvisorMay 22, 2024
New COVID-19 Treatments Add-On Payment (NCTAP)Last modified December 13, 2022
New report on UK excess deaths
New VAERS analysis reveals hundreds of serious adverse events that the CDC and FDA never told us aboutNovember 9, 2021
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 VaccinationSeptember 28, 2022
New-onset autoimmune phenomena post-COVID-19 vaccinationDecember 27, 2021
New-onset psychosis following COVID-19 vaccination: a systematic reviewApril 12, 2024
News release: FDA Approves First COVID-19 VaccineAugust 23, 2021
News release: FDA Approves First Treatment for COVID-19October 22, 2020
News release: FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 VaccineDecember 18, 2020
NHS key statistics: EnglandNovember 15, 2023
NIH Documents Provide New Evidence U.S. Funded Gain-of-Function Research in WuhanSeptember 9, 2021
Ninety-third SAGE meeting on COVID-19July 7, 2021
Ninth Amendment to Declaration Under the Public Readiness and Emergency Preparedness (PREP} Act for Medical Countermeasures Against COVID-19September 14, 2021
No difference in risk of hospitalisation between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in NorwayDecember 10, 2021
No learning loss in Sweden during the pandemic: Evidence from primary school reading assessmentsJune 2, 2022
No Nanobots in Vaccines — Just Lipids on the LooseSeptember 10, 2024
Nobel Laureate Luc Montagnier - Warns Covid Vaccine May Lead to 'Neurodegenerative Illness'May 27, 2021
Non-COVID Excess Deaths, 2020-21: Collateral Damage of Policy Choices?June 2022
Non-COVID-19 excess deaths by age and gender in the United States during the first three months of the COVID-19 pandemicOctober 10, 2020
Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza2019
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)January 8, 2021
Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental MeasuresMay 2020
Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021September 23, 2021
NSW COVID-19 Weekly Data Overview: Epidemiological weeks 51 and 52, ending 31 December 2022December 31, 2022
Off-label prescribingDecember 2, 2013
Official mortality data for England suggest systematic miscategorisation of vaccine status and uncertain effectiveness of Covid-19 vaccinationJanuary 12, 2022
On COVID vaccines: why they cannot work, and irrefutable evidence of their causative role in deaths after vaccination
On the Mask Study: An Interview with the AuthorFebruary 28, 2023
On the use of the Pfizer and the Moderna COVID-19 mRNA vaccines in children and adolescentsApril 29, 2022
Oncogenesis and autoimmunity as a result of mRNA COVID-19 vaccinationApril 23, 2024
One number could help reveal how infectious a COVID-19 patient is. Should test results include it?September 29, 2020
One Page Summary of the Clinical Trials Evidence for Ivermectin in COVID-19January 11, 2021
One Year after Mild COVID-19: The Majority of Patients Maintain Specific Immunity, But One in Four Still Suffer from Long-Term SymptomsJuly 27, 2021
Open Knowledge Commons versus Privatized Gain in a Fractured Information Ecology: Lessons from COVID-19 for the Future of SustainabilityAugust 19, 2020
Open Letter and Notice of Liability from Doctors and Scientists to the EMA and the Members of the European Parliament Regarding COVID-19 VaccinationSeptember 13, 2021
Open letter from Florida Surgeon General to FDA Commissioner and CDC DirectorDecember 6, 2023
Open letter from medical doctors and health professionals to all Belgian authorities and all Belgian mediaSeptember 5, 2020
Open Letter from the UK Medical Freedom Alliance to Members of the House of LordsJanuary 3, 2022
Open Letter to the Honorable Xavier Becerra, Secretary of US Department of Health and Human ServicesJanuary 11, 2022
Open Letter to the MHRA Regarding Child Death Data: Signals that Covid-19 Vaccines may have caused death in children and young adultsJanuary 19, 2022
Open Letter to the World Health OrganizationMarch 6, 2021
Open Letter: Letter by NZ Doctors with Concerns Over Pfizer VaccineApril 27, 2021